دورية أكاديمية
Effects of repeated abobotulinumtoxinA injections in upper limb spasticity.
| العنوان: | Effects of repeated abobotulinumtoxinA injections in upper limb spasticity. |
|---|---|
| المؤلفون: | Gracies JM; EA 7377 BIOTN, Université Paris-Est Créteil, Service de Rééducation Neurolocomotrice, Hôpitaux Universitaires Henri Mondor, 51, avenue du Maréchal De Lattre De Tassigny, 94010, Créteil, France., O'Dell M; Department of Rehabilitation Medicine, Weill Cornell Medicine, Baker Pavilion, New York, New York, USA., Vecchio M; Department of U.O. Physical Medicine and Rehabilitation, Policlinico Vittorio Emanuele University Hospital, Catania, Italy., Hedera P; Department of Neurology, Division of Movement Disorders, Vanderbilt University, Nashville, Tennessee, USA., Kocer S; Centre de Rééducation Hôpital du Jura, Porrentruy, Switzerland., Rudzinska-Bar M; Department of Neurology, Faculty of Medicine, Medical University of Silesia, Katowice, Poland., Rubin B; Design Neuroscience Center, Doral, Florida, USA., Timerbaeva SL; Research Center of Neurology, Moscow, Russia., Lusakowska A; Department of Neurology, Medical University of Warsaw, Poland., Boyer FC; EA 3797, Unités de Médecine Physique et de Réadaptation, Hôpital Universitaire Sébastopol, Champagne Ardenne, France., Grandoulier AS; Ipsen Innovation, Les Ulis, France., Vilain C; Ipsen Innovation, Les Ulis, France., Picaut P; Ipsen Innovation, Les Ulis, France. |
| مؤلفون مشاركون: | International AbobotulinumtoxinA Adult Upper Limb Spasticity Study Group |
| المصدر: | Muscle & nerve [Muscle Nerve] 2018 Feb; Vol. 57 (2), pp. 245-254. Date of Electronic Publication: 2017 Aug 13. |
| نوع المنشور: | Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't |
| اللغة: | English |
| بيانات الدورية: | Publisher: John Wiley & Sons Country of Publication: United States NLM ID: 7803146 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-4598 (Electronic) Linking ISSN: 0148639X NLM ISO Abbreviation: Muscle Nerve Subsets: MEDLINE |
| أسماء مطبوعة: | Publication: <2005-> : Hoboken, NJ : John Wiley & Sons Original Publication: New York, NY : John Wiley & Sons |
| مواضيع طبية MeSH: | Botulinum Toxins, Type A/*therapeutic use , Muscle Spasticity/*drug therapy , Neuromuscular Agents/*therapeutic use , Upper Extremity/*physiopathology, Adult ; Aged ; Botulinum Toxins, Type A/administration & dosage ; Botulinum Toxins, Type A/adverse effects ; Disability Evaluation ; Double-Blind Method ; Elbow/physiopathology ; Female ; Fingers/physiopathology ; Humans ; Injections, Intramuscular ; Male ; Middle Aged ; Muscle Spasticity/physiopathology ; Muscle Tonus/drug effects ; Neuromuscular Agents/administration & dosage ; Neuromuscular Agents/adverse effects ; Range of Motion, Articular/drug effects ; Treatment Outcome ; Wrist/physiopathology |
| مستخلص: | Introduction: The efficacy of single injections of abobotulinumtoxinA (Dysport) is established in adults with upper limb spasticity. In this study we assessed the effects of repeated injections of abobotulinumtoxinA over 1 year. Methods: Patients (n = 258, safety population) received 500 U, 1,000 U, or 1,500 U (1,500-U dose included 500-U shoulder injections) for up to 4 or 5 treatment cycles. Assessments included treatment-emergent adverse events (TEAEs), muscle tone, passive and active range of motion (X Results: The incidence of TEAEs decreased across cycles. Muscle tone reduction and X Discussion: A favorable safety profile and continuous improvements in active movements and perceived and active function were associated with repeated abobotulinumtoxinA injections in upper limb muscles. Muscle Nerve 57: 245-254, 2018. (© 2017 The Authors Muscle & Nerve Published by Wiley Periodicals, Inc.) |
| References: | Ann Med. 2001 Jul;33(5):337-43. (PMID: 11491192) Clin Rehabil. 2014 Mar;28(3):232-42. (PMID: 23945164) Clin Neurophysiol. 2013 Mar;124(3):528-35. (PMID: 23063291) Aust J Physiother. 2006;52(2):129-33. (PMID: 16764550) Phys Ther. 2014 Nov;94(11):1569-81. (PMID: 25060957) J Rehabil Med. 2011 May;43(6):486-92. (PMID: 21533328) Qual Life Res. 2016 Jun;25(6):1585-96. (PMID: 26714699) Neurology. 2016 May 10;86(19):1818-26. (PMID: 27164716) Lancet Neurol. 2015 Oct;14(10):992-1001. (PMID: 26318836) Disabil Rehabil. 2005 Feb 18;27(4):176-84. (PMID: 15824048) Neurology. 2004 Nov 23;63(10):1971-3. (PMID: 15557529) Stroke. 2011 May;42(5):1371-9. (PMID: 21415398) Clin Rehabil. 2016 Jun;30(6):617-22. (PMID: 26141809) Med Care. 1993 Mar;31(3):247-63. (PMID: 8450681) Clin Rehabil. 2016 Jun;30(6):577-86. (PMID: 26292692) J Rehabil Med. 2009 Jan;41(1):13-25. (PMID: 19197564) Clin Rehabil. 2006 Feb;20(2):173-82. (PMID: 16541938) Neurorehabil Neural Repair. 2014 Jan;28(1):24-35. (PMID: 23911972) Am J Phys Med Rehabil. 2000 Jul-Aug;79(4):377-84; quiz 391-4. (PMID: 10892624) Ann Phys Rehabil Med. 2015 Jun;58(3):173-8. (PMID: 26027752) Neurology. 2008 May 6;70(19):1691-8. (PMID: 18458229) J Neurol Sci. 2016 Dec 15;371:6-14. (PMID: 27871449) Arch Phys Med Rehabil. 2010 Mar;91(3):421-8. (PMID: 20298834) Clin Rehabil. 2000 Feb;14(1):5-13. (PMID: 10688339) Am J Phys Med Rehabil. 2015 Mar;94(3):229-38. (PMID: 25299523) J Neurol Neurosurg Psychiatry. 2010 Jan;81(1):46-52. (PMID: 19770162) Neurorehabil Neural Repair. 2012 Sep;26(7):812-21. (PMID: 22371239) BMJ Open. 2013 Jun 20;3(6):null. (PMID: 23794582) Arch Phys Med Rehabil. 2013 May;94(5):977-89. (PMID: 23262381) Arch Phys Med Rehabil. 2002 Oct;83(10 ):1349-54. (PMID: 12370866) Eur J Phys Rehabil Med. 2010 Sep;46(3):411-21. (PMID: 20927007) Muscle Nerve. 2005 May;31(5):535-51. (PMID: 15714510) J Neural Transm (Vienna). 2008;115(4):617-23. (PMID: 18322637) Arch Phys Med Rehabil. 2007 Aug;88(8):1022-9. (PMID: 17678665) Arch Phys Med Rehabil. 2008 May;89(5):799-806. (PMID: 18452724) Eur J Neurol. 2010 Aug;17 Suppl 2:74-93. (PMID: 20633180) Muscle Nerve. 2005 May;31(5):552-71. (PMID: 15714511) J Neurol Sci. 2014 Feb 15;337(1-2):86-90. (PMID: 24361062) Health Serv Res. 2007 Dec;42(6 Pt 1):2257-74; discussion 2294-323. (PMID: 17995565) Arch Phys Med Rehabil. 2013 Dec;94(12):2494-501. (PMID: 23851419) J Pediatr Orthop. 2005 May-Jun;25(3):286-91. (PMID: 15832139) J Rehabil Med. 2009 Jun;41(7):536-44. (PMID: 19543664) Phys Ther. 1987 Feb;67(2):206-7. (PMID: 3809245) |
| فهرسة مساهمة: | Keywords: active function; botulinum toxin; open label; stroke; traumatic brain injury; upper limb spasticity |
| المشرفين على المادة: | 0 (Neuromuscular Agents) EC 3.4.24.69 (Botulinum Toxins, Type A) EC 3.4.24.69 (abobotulinumtoxinA) |
| تواريخ الأحداث: | Date Created: 20170608 Date Completed: 20190128 Latest Revision: 20190128 |
| رمز التحديث: | 20231215 |
| مُعرف محوري في PubMed: | PMC5811783 |
| DOI: | 10.1002/mus.25721 |
| PMID: | 28590525 |
| قاعدة البيانات: | MEDLINE |
Full Text Finder | تدمد: | 1097-4598 |
|---|---|
| DOI: | 10.1002/mus.25721 |